• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人肺泡巨噬细胞通过TLR2和TLR4检测严重急性呼吸综合征冠状病毒2(SARS-CoV-2)包膜蛋白并分泌细胞因子作为应答。

Human Alveolar Macrophages Detect SARS-CoV-2 Envelope Protein Through TLR2 and TLR4 and Secrete Cytokines in Response.

作者信息

Grant Conor, Duffin Emily, O'Connell Finbarr, Nadarajan Parthiban, Bergin Colm, Keane Joseph, O'Sullivan Mary P

机构信息

Department of Clinical Medicine, Trinity Translational Medicine Institute, St. James's Hospital, Trinity College Dublin, the University of Dublin, Dublin, Ireland.

Department of Infectious Diseases, Trinity Translational Medicine Institute, St. James's Hospital, Trinity College Dublin, the University of Dublin, Dublin, Ireland.

出版信息

Immunology. 2025 Jul;175(3):391-401. doi: 10.1111/imm.13922. Epub 2025 May 4.

DOI:10.1111/imm.13922
PMID:40320615
Abstract

Alveolar macrophages (AMs) are the most numerous immune cells of the lung and are the resident, sentinel lung immunocytes that summon trafficking immune cells to the compartment. Immune profiling of AMs from COVID-19 patients implicates AMs in the immune circuits that drive pulmonary inflammation in severe COVID-19 infection. However, little is known about human AM responses to SARS-CoV-2 proteins, such as the spike protein and envelope protein. We aimed to understand if human AMs recognize SARS-CoV-2 proteins and how they respond. We found that human AMs do not sense SARS-CoV-2 spike protein but do sense envelope protein via the pattern recognition receptors TLR2 and TLR4, secreting IL-1β, IFNγ, IL-12p70, IL-6, and TNFα in response. AMs from donors over the age of 70 years produced significantly more cytokines than those from younger patients following stimulation with SARS-CoV-2 envelope protein. AMs from current smokers had lower cytokine secretion. This is the first report of human AMs producing cytokines in response to SARS-CoV-2 proteins and the first to correlate those responses with clinical risk factors. These results may partly explain why older adults are at such high risk of severe lung inflammation in COVID-19.

摘要

肺泡巨噬细胞(AMs)是肺中数量最多的免疫细胞,是驻留的、哨兵样的肺免疫细胞,可召集游走免疫细胞至该区域。对新冠病毒病(COVID-19)患者的AMs进行免疫分析表明,AMs参与了在严重COVID-19感染中驱动肺部炎症的免疫回路。然而,关于人类AMs对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)蛋白(如刺突蛋白和包膜蛋白)的反应知之甚少。我们旨在了解人类AMs是否能识别SARS-CoV-2蛋白以及它们如何做出反应。我们发现人类AMs无法感知SARS-CoV-2刺突蛋白,但能通过模式识别受体Toll样受体2(TLR2)和Toll样受体4(TLR4)感知包膜蛋白,并相应地分泌白细胞介素-1β(IL-1β)、干扰素γ(IFNγ)、白细胞介素-12p70(IL-12p70)、白细胞介素-6(IL-6)和肿瘤坏死因子α(TNFα)。在接受SARS-CoV-2包膜蛋白刺激后,70岁以上供体的AMs产生的细胞因子明显多于年轻患者的AMs。目前吸烟者的AMs细胞因子分泌较低。这是关于人类AMs对SARS-CoV-2蛋白产生细胞因子反应的首次报告,也是首次将这些反应与临床风险因素相关联的报告。这些结果可能部分解释了为什么老年人在COVID-19中发生严重肺部炎症的风险如此之高。

相似文献

1
Human Alveolar Macrophages Detect SARS-CoV-2 Envelope Protein Through TLR2 and TLR4 and Secrete Cytokines in Response.人肺泡巨噬细胞通过TLR2和TLR4检测严重急性呼吸综合征冠状病毒2(SARS-CoV-2)包膜蛋白并分泌细胞因子作为应答。
Immunology. 2025 Jul;175(3):391-401. doi: 10.1111/imm.13922. Epub 2025 May 4.
2
Effects of budesonide on toll-like receptor expression in alveolar macrophages from smokers with and without COPD.布地奈德对伴有和不伴有慢性阻塞性肺疾病(COPD)的吸烟者肺泡巨噬细胞中Toll样受体表达的影响。
Int J Chron Obstruct Pulmon Dis. 2016 May 17;11:1035-43. doi: 10.2147/COPD.S102668. eCollection 2016.
3
SARS-CoV-2 evades immune detection in alveolar macrophages.SARS-CoV-2 在肺泡巨噬细胞中逃避免疫检测。
EMBO Rep. 2020 Dec 3;21(12):e51252. doi: 10.15252/embr.202051252. Epub 2020 Oct 28.
4
Tobacco smoking inhibits expression of proinflammatory cytokines and activation of IL-1R-associated kinase, p38, and NF-kappaB in alveolar macrophages stimulated with TLR2 and TLR4 agonists.吸烟会抑制用TLR2和TLR4激动剂刺激的肺泡巨噬细胞中促炎细胞因子的表达以及IL-1R相关激酶、p38和核因子κB的激活。
J Immunol. 2007 Nov 1;179(9):6097-106. doi: 10.4049/jimmunol.179.9.6097.
5
The effects of repeated Toll-like receptors 2 and 4 stimulation in COPD alveolar macrophages.慢性阻塞性肺疾病肺泡巨噬细胞中Toll样受体2和4反复刺激的影响
Int J Chron Obstruct Pulmon Dis. 2018 Mar 2;13:771-780. doi: 10.2147/COPD.S97071. eCollection 2018.
6
Differential Effect of SARS-CoV-2 Spike Glycoprotein 1 on Human Bronchial and Alveolar Lung Mucosa Models: Implications for Pathogenicity.SARS-CoV-2 刺突糖蛋白 1 对人支气管和肺泡肺黏膜模型的差异作用:对致病性的影响。
Viruses. 2021 Dec 17;13(12):2537. doi: 10.3390/v13122537.
7
Convalescent COVID-19 monocytes exhibit altered steady-state gene expression and reduced TLR2, TLR4 and RIG-I induced cytokine expression.新冠康复者的单核细胞表现出稳态基因表达改变,且Toll样受体2、Toll样受体4和维甲酸诱导基因I介导的细胞因子表达降低。
Hum Immunol. 2025 Mar;86(2):111249. doi: 10.1016/j.humimm.2025.111249. Epub 2025 Feb 7.
8
SARS-CoV-2 spike protein induces inflammation via TLR2-dependent activation of the NF-κB pathway.SARS-CoV-2 刺突蛋白通过 TLR2 依赖性激活 NF-κB 途径诱导炎症反应。
Elife. 2021 Dec 6;10:e68563. doi: 10.7554/eLife.68563.
9
COVID-19 and Toll-Like Receptor 4 (TLR4): SARS-CoV-2 May Bind and Activate TLR4 to Increase ACE2 Expression, Facilitating Entry and Causing Hyperinflammation.COVID-19 和 Toll 样受体 4(TLR4):SARS-CoV-2 可能结合并激活 TLR4 以增加 ACE2 的表达,从而促进进入并导致过度炎症。
Mediators Inflamm. 2021 Jan 14;2021:8874339. doi: 10.1155/2021/8874339. eCollection 2021.
10
Diverse Humoral Immune Responses in Younger and Older Adult COVID-19 Patients.年轻和老年 COVID-19 患者的不同体液免疫反应。
mBio. 2021 Jun 29;12(3):e0122921. doi: 10.1128/mBio.01229-21.

引用本文的文献

1
Advanced nanotherapies for precision treatment of inflammatory lung diseases.用于炎症性肺病精准治疗的先进纳米疗法。
Bioact Mater. 2025 Jul 20;53:329-365. doi: 10.1016/j.bioactmat.2025.07.028. eCollection 2025 Nov.

本文引用的文献

1
SARS-CoV-2 envelope protein regulates innate immune tolerance.严重急性呼吸综合征冠状病毒2包膜蛋白调节先天性免疫耐受。
iScience. 2024 May 15;27(6):109975. doi: 10.1016/j.isci.2024.109975. eCollection 2024 Jun 21.
2
SARS-CoV-2 envelope protein impairs airway epithelial barrier function and exacerbates airway inflammation via increased intracellular Cl concentration.SARS-CoV-2 包膜蛋白通过增加细胞内 Cl-浓度损害气道上皮屏障功能并加剧气道炎症。
Signal Transduct Target Ther. 2024 Mar 25;9(1):74. doi: 10.1038/s41392-024-01753-z.
3
CD36 mediates SARS-CoV-2-envelope-protein-induced platelet activation and thrombosis.
CD36 介导严重急性呼吸综合征冠状病毒 2 包膜蛋白诱导的血小板活化和血栓形成。
Nat Commun. 2023 Aug 21;14(1):5077. doi: 10.1038/s41467-023-40824-7.
4
SARS-CoV-2 Spike Protein Activates Human Lung Macrophages.SARS-CoV-2 刺突蛋白激活人肺巨噬细胞。
Int J Mol Sci. 2023 Feb 3;24(3):3036. doi: 10.3390/ijms24033036.
5
Activation of TLR4 by viral glycoproteins: A double-edged sword?病毒糖蛋白激活Toll样受体4:一把双刃剑?
Front Microbiol. 2022 Sep 29;13:1007081. doi: 10.3389/fmicb.2022.1007081. eCollection 2022.
6
Advanced age is associated with changes in alveolar macrophages and their responses to the stress of traumatic injury.高龄与肺泡巨噬细胞的变化及其对创伤性损伤应激的反应有关。
J Leukoc Biol. 2022 Dec;112(6):1371-1386. doi: 10.1002/JLB.3HI0620-399RR. Epub 2022 Sep 19.
7
SARS-CoV-2 spike and nucleocapsid proteins fail to activate human dendritic cells or γδ T cells.SARS-CoV-2 刺突蛋白和核衣壳蛋白不能激活人树突状细胞或 γδ T 细胞。
PLoS One. 2022 Jul 14;17(7):e0271463. doi: 10.1371/journal.pone.0271463. eCollection 2022.
8
Evolution of SARS-CoV-2 in Spain during the First Two Years of the Pandemic: Circulating Variants, Amino Acid Conservation, and Genetic Variability in Structural, Non-Structural, and Accessory Proteins.SARS-CoV-2 在大流行的头两年中在西班牙的进化:流行变异株、结构蛋白、非结构蛋白和辅助蛋白中的氨基酸保守性和遗传变异性。
Int J Mol Sci. 2022 Jun 7;23(12):6394. doi: 10.3390/ijms23126394.
9
SARS-CoV-2 Envelope (E) Protein Binds and Activates TLR2 Pathway: A Novel Molecular Target for COVID-19 Interventions.SARS-CoV-2 包膜(E)蛋白结合并激活 TLR2 途径:COVID-19 干预的新分子靶标。
Viruses. 2022 May 8;14(5):999. doi: 10.3390/v14050999.
10
An Overview of Vaccine Adjuvants: Current Evidence and Future Perspectives.疫苗佐剂概述:当前证据与未来展望
Vaccines (Basel). 2022 May 22;10(5):819. doi: 10.3390/vaccines10050819.